Update Cambrex adding lab space, to hire 14 chemists 31-Jan-2018 By Melissa Fassbender Cambrex Corporation continues to expand its analytical development capabilities as part of its strategic plan to increase capacity in North America.
CorePharma to reopen under new ownership following Impax sale 31-Jan-2018 By Melissa Fassbender Impax Laboratories has sold its CorePharma facilities and equipment to a group of industry investors which aim to reestablish the company as a "preferred partner of choice," says new CEO.
PEOPLE ON THE MOVE Outsourcing-Pharma's Hiring and Firing Roundup January '18 31-Jan-2018 By Melissa Fassbender New hires in the new year abound, with several c-suite appointments at AMRI, Synteract, WuXi Biologics, Patient iP, and others.
FDA upgrades Kansas plant but Hospira’s legacy continues to haunt Pfizer 31-Jan-2018 By Dan Stanton The US FDA has upgraded the status of Pfizer’s McPherson manufacturing, hit with a warning letter last year.
Japanese API maker accused of falsifying data by US FDA 31-Jan-2018 By Dan Stanton The US FDA has slammed Daito Kasei Kogyo Co in a warning letter for data integrity issues.
Intas puts the fizz back into ex-Sanofi plant with generic effervescents 31-Jan-2018 By Flora Southey Intas Pharmaceuticals says it ‘worked hard’ over two years to bring an ex-Sanofi manufacturing facility back into production in Newcastle, UK.